Combining CTLA-4 and angiopoietin-2 blockade in patients with advanced melanoma: a phase I trial.

Patrick A OttMatthew NazzaroKathleen L PfaffEvisa GjiniKristen D FeltJacquelyn O WolffElizabeth I BuchbinderRizwan HaqRyan J SullivanDonald P LawrenceDavid F McDermottMariano SevergniniAnita Giobbie-HurderScott J RodigF Stephen Hodi

Published in: Journal for immunotherapy of cancer (2022)

NCT02141542.

Keyphrases

phase iii
study protocol
phase ii
clinical trial
skin cancer
randomized controlled trial
open label
basal cell carcinoma